Ahead of The Union World Conference on Lung Health, Katherine Horton provides @the-independent.com with insights into the devastating impact of the funding cuts on global health, particularly tuberculosis. Be sure to read about the threat of UK aid cuts: www.independent.co.uk/news/uk/poli...

📰 New Position Paper A paradigm shift in corticosteroid therapy for #sarcoidosis: a World Association of Sarcoidosis and Other Granulomatous Disorders Position Paper, endorsed by the Americas Association of Sarcoidosis and Other Granulomatous Disorders www.thelancet.com/journals/lan...

The 2025 @lancetcountdown.bsky.social report reveals climate change inaction is costing lives and livelihoods, and harming the economy. During #COP30, explore recommendations for action: spkl.io/63324AbjGM#COP30#LancetClimate25

📰 News US lung cancer report suggests years of encouraging progress under threat from health agency cuts Written by Tony Kirby www.thelancet.com/journals/lan...

🌍 Climate change and #tuberculosis 🔹 Commissioned by @whowpro.bsky.social, the authors developed an analytical framework outlining potential causal relationships between climate change and TB, highlighting the need to consider TB as a climate-sensitive disease 🖇️ tinyurl.com/4ccn5kad

Our framework that informed the @who.int TB & climate change policy brief out now in @lancetrespirmed.bsky.social, exploring the intersections and implications of climate change for the TB epidemic. Key message? TB should be considered a climate-sensitive disease www.thelancet.com/journals/lan...

🍂 🍁 The Lancet Respiratory Medicine’s November issue is out now! 📜 This issue includes groundbreaking work on IPF, asthma, and breathlessness, among many other #respmed and #criticalcare topics Check out the full issue here: www.thelancet.com/journals/lan...

🌟 Fantastic to see this Article named as the RCGP Research Paper of the Year! Nasal sprays and behavioural interventions compared with usual care for acute respiratory illness in primary care: a randomised, controlled trial ⛓️‍💥 Read the full paper here: www.thelancet.com/journals/lan...

🚨 New Editorial Redefining outcomes in #asthma —remission and beyond "Even though a cure for asthma is at this point aspirational, having cure as a target is the first step to achieving this goal" www.thelancet.com/journals/lan...

📰 New cohort study: Association of medication-induced deep sedation and emotional distress during mechanical ventilation with loss of independent living Lighter sedation was associated with lower risk of loss of independent living www.thelancet.com/journals/lan...

🗞️ News: European Respiratory Society International Congress 2025 This round up features exciting breakthroughs and updates on trials in #COPD, #PAH, #IPF and #bronchiectasis The 2025 ERS Congress was held in Amsterdam, Netherlands from Sept 27–Oct 1, 2025 ⛓️‍💥 Read in full here: tinyurl.com/3r6zepfd

🔔 Introducing The Lancet Regional Health – Africa, a new #goldopenaccess journal promoting the advancement of clinical practice and health policy in Africa. Explore the new journal at hubs.li/Q03KzMp00 #MedSky

ICYMI: Our new cross-journal Series with @thelancet.com on #Asthma is now live: www.thelancet.com/series-do/as...

🫁 Explore our October 2025 issue, out now in print and online! This issue covers a multitude of respiratory and critical care content including mechanical ventilation, #NSCLC, #bronchiectasis, as well as out-of-hospital cardiac arrest. www.thelancet.com/issue/S2213-... #respmed #lungsky

300 million people have asthma. A joy co-authoring this @lancetrespirmed.bsky.social MS: Genetic+ environmental risk factors for asthma: towards prevention, led by G Koppelman+G Bruselle with @erikmelen.bsky.social+ M Pino as co-authors @atscommunity.bsky.social authors.elsevier.com/c/1ls9A7tFB1...

🫁 Asthma 2025 🫁 New Series on #Asthma, launched today at #ERSCongress Check out the Series hub here: www.thelancet.com/series-do/as... 👩‍⚕️ In this Series, we provide new insights into the genetics, prevention, and risk factors of the disease; monoclonal antibody therapeutics; and remission

⏰#ERSCongress ALERT 📰 #Morphine for chronic #breathlessness (MABEL) in the UK: a multi-site, parallel-group, dose titration, double-blind, RCT This study found no evidence that morphine improves worst breathlessness intensity Online now and free to access: www.thelancet.com/journals/lan...

King’s researchers Irene Higginson & @sbajwah.bsky.social contributed to the MABEL trial, published today in @lancetrespirmed.bsky.social, examining the role of morphine in chronic breathlessness. 🔗 www.thelancet.com/journals/lan...

⏰#ERSCongress ALERT 📰 Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial 🔓 Online now and free to access for all: tinyurl.com/4nhbtj89

🌍 New @lancetrespirmed.bsky.social! Pooled sputum testing for TB: revisiting a cost-saving innovation 🚫 Let's bust pooling myths & misconceptions! 🔬 Pooling is efficient, accurate, cost-saving & improves equity of access! 📖 Read at doi.org/10.1016/S221... Thanks @unitaid.bsky.social for funding!

💡New Spotlight: Chronic respiratory diseases and inhalers in Africa Esther Nakkazi reports on chronic respiratory diseases as a neglected health crisis ahead of the 4th High-level Meeting of the UN General Assembly in New York on Sept 25, 2025 tinyurl.com/yejfbz2v

🌉 Only a few days now until #ERSCongress in Amsterdam! 📰 We will be launching our new cross-journal Series with @thelancet.com on #asthma on 30th September at 10:15 CEST 📅The Lancet Group will be publishing plenty of new respiratory content during the conference so keep an eye out for updates!

📈 New phase 3 trial in #lungcancer Retifanlimab vs placebo with platinum-based chemotherapy in patients with first-line metastatic non-small-cell lung cancer (POD1UM-304) Retifanlimab improved overall survival compared with placebo when added to platinum-based chemotherapy tinyurl.com/483jf7k8

📚 New Editorial Farming life: a double-edged sword for respiratory health The #farming environment is an exemplar of disparate and antagonistic influences on respiratory health www.thelancet.com/journals/lan...

💡Spotlight Chrysotile asbestos—the deadly consequences of a retreat from national bans "There is no safe level of asbestos, whether chrysotile or amphibole, and global bans remain the only solution to this ongoing devastating occupational health tragedy" tinyurl.com/5n7rctz2

📰The Lancet Respiratory Medicine’s September issue is out now Read content on obstructive sleep apnoea, #tuberculosis, cardiogenic shock, #pneumonia, and much more Check out the full issue here: bit.ly/3P2PVls

🗞️ News Vaccine disinformation motivated gunman's attack on US CDC headquarters @bryantfurlow.bsky.social tinyurl.com/mu2nen8d

Abrupt funding cuts to international aid are disrupting essential tuberculosis (TB) services. Ending TB remains within reach—but only with adequate adaptation, investment, and will. New Comment ⤵️ tinyurl.com/2xccptr5

🌎 Symposium Spotlight Join us at the Union World conference on Lung Health for a critical symposium with The Lancet Global Health Commission on Medical Oxygen Security. 🗓️18 November 2025 ⏰ 11:30 - 13:00

📰 The US FDA has approved the first immunotherapy for recurrent respiratory papillomatosis tinyurl.com/3db69ye4 Approval is based on a pivotal phase 1/2 clinical trial of PRGN-2012 gene therapy published in @lancetrespirmed.bsky.social 🔗 Check out the full trial results here: tinyurl.com/yzjdc665

💡New Spotlight Unique perspective on cystic fibrosis at @edfringe.bsky.social by Peter Ranscombe tinyurl.com/5r8sykbn

📄✨ New publication! A @lancetrespirmed.bsky.social study co-authored by #AusHSI Prof Stephanie Yerkovich and Prof Anne Chang highlights geographical variations in childhood bronchiectasis and its management using data from the international Child-BEAR-Net Registry. 🔗 Read the paper: bit.ly/46RdLdx

The Trump administration’s sweeping deregulation, funding cuts, and layoffs are undermining workplace respiratory health protection and research, say experts. Explore what it means for workers in @lancetrespirmed.bsky.social ⤵️ bit.ly/3J7jW3d

🗞️ News from the US covered by @bryantfurlow.bsky.social Trump administration decimates worker health oversight tinyurl.com/3kpx4fdf US FDA authorises Juul e-cigarette marketing, imperilling youth #vaping declines tinyurl.com/23hn996v

New Comment - Pre-#COPD: an evolving concept with practice potential The concept of pre-COPD holds strong potential for both clinical and public health strategies 🔗 tinyurl.com/4a6wtcds

🎙️For new followers, our Podcast is a monthly audio companion to the journal, covering all things respiratory and critical care, from #longCOVID to #tobacco control, #asthma, #TB, #sepsis, and more 🎧Listen to previous episodes here: www.buzzsprout.com/admin/145996... #lungsky #MedSky

So honoured and humbled to be profiled by @lancetrespirmed.bsky.social

📑 New Article available #OpenAccess Type 2 inflammation biomarkers and their association with response to dupilumab in #COPD (BOREAS): an analysis of a randomised, placebo-controlled, phase 3 trial tinyurl.com/b34yzm3v #lungsky #respmed

📚 August issue of The Lancet Respiratory Medicine out now! Read the full issue here: lnkd.in/eh_i8K2k This issue includes groundbreaking research on #NSCLC, #COPD, and #bronchiectasis, alongside important discussion on a variety of #respiratory and #criticalcare topics

🎙️Check out our latest podcast, accompanying our Series on the Global Epidemiology of Chronic Respiratory Disease 🫁 Diana Stanley is joined by Joan Soriano to discuss the Series, exploring diagnostic challenges, global trends, and future directions for prevention 🎧Listen here: tinyurl.com/2p5a8273

The Union World Conference on Lung Health is a vital source of the latest breakthroughs in tuberculosis and lung disease. 📰 Even now, studies presented last year in Bali, Indonesia are being published, like the endTB-Q trial in @lancetrespirmed.bsky.social: www.thelancet.com/journals/lan...

🚨New phase 4 trial: Effect of riociguat on exercise after balloon pulmonary angioplasty in inoperable #CTEPH (THERAPY-HYBRID-BPA) Findings suggested that continuation of riociguat post-BPA might attenuate the worsening of exercise intolerance without increasing adverse events tinyurl.com/y7yh8bkp

Chronic respiratory diseases constitute one of the most pressing, yet underappreciated, global health burdens. A new @lancetrespirmed.bsky.social Series explores the epidemiology of asthma, COPD, & ILD & discusses policy solutions to improve diagnosis & access to care: tinyurl.com/mpuv4jsj

🖼️ Infographic: Facing the looming rise in global #asthma cases tinyurl.com/5bhca654 The number of individuals with asthma worldwide is expected to grow, particularly in deprived areas Explore our infographic, and read the full paper here: tinyurl.com/2s45kbff

🎙️NUOVO Podcast (in Italian) Lorenzo Guglielmetti parla dello studio clinico endTB-Q per valutare l’efficacia e la sicurezza di un regime di farmaci per curare la #tubercolosi in individui con pre-XDR tubercolosi. 🎧Ascoltatelo 👉 tinyurl.com/4bfkzhud 🔗E leggete l'articolo 👉 tinyurl.com/4y4kf35y

🚨New Series: Global Epidemiology of Chronic Respiratory Disease This Series focuses on the global epidemiology of #asthma, #COPD, and #ILD, and a Policy Review on #tobacco, the main, avoidable risk factor of lung disease, completes the Series. 🔗 www.thelancet.com/series-do/gl...

🎙️NEW Podcast We were pleased to be joined by Dr Mitnick & Dr Guglielmetti to discuss the endTB-Q trial to evaluate the efficacy and safety of a drug regiment to treat #TB in individuals with pre-XDR tuberculosis. 🎧Listen here: tinyurl.com/mw2u2u8z 🔗Read the full article: tinyurl.com/4y4kf35y

📚 New Viewpoint #OpenAccess 📑Eosinophils in #asthma phenotypes: perpetrators or guilty by association? "Data suggest that eosinophilia should not be considered a #TreatableTrait in people with chronic airway diseases, but only a complement to an accurate clinical diagnosis" 🔗 tinyurl.com/2bve3dne

▶️ Evaluation of the effect of multimorbidity on difficult-to-treat #asthma using a novel score (MiDAS): a multinational study of asthma cohorts Findings indicate that an airway-centric approach is inadequate and that multidisciplinary care is imperative 🔗 Read more here: tinyurl.com/yrbn7h4x